Misoprostol alone for early abortion: an evaluation of seven potential regimens

被引:30
作者
Blanchard, K [1 ]
Shochet, T
Coyaji, K
Ngoc, NTN
Winikoff, B
机构
[1] Ibis Reprod Hlth, Cambridge, MA 02138 USA
[2] Populat Council, New York, NY USA
[3] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[4] KEM Hosp, Dept Obstet & Gynecol, Rasta Peth 411011, Rao, India
[5] Hungvuong Hosp, Ho Chi Minh City Q5, Vietnam
[6] Gynu Hlth Projects, New York, NY 10010 USA
关键词
misoprostol; medical abortion; pregnancy termination;
D O I
10.1016/j.contraception.2005.02.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: A growing body of literature has shown that misoprostol alone could be effective for early medical abortion. We evaluated seven potential regimens in women up to 56 days of gestation in order to potentially identify an optimal regimen. Methods: In phase I of the study, women requesting early abortion were randomized to one of three misoprostol regimens (4 X 400 mu g po every 3 h, 2 x 800 mu g po every 6 h, 1 x 600 pv mu g); in phase II, women were randomized to one of two regimens (2 X 800 mu g po every 3 h, 1 x 800 pv mu g). In phase III, we consecutively tested two regimens (800 mu g pv wetted with saline repeated after 24 h if intact gestational sac, 2 X 800 mu g pv wetted with saline) to validate previously published results. Results: Although most women experienced some side effects, all regimens were tolerable and acceptable. Five of the seven regimens resulted in complete abortion rates of 60% or less. Only repeated doses of 800 mu g pv misoprostol resulted in efficacy exceeding 60%. Discussion: Misoprostol-alone abortion regimens using oral misoprostol are too ineffective for clinical use or further investigation. Regimens with repeated dosing of misoprostol 800 mu g pv warrant further study to find the optimal treatment protocol. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 33 条
[1]   Two regimens of misoprostol for treatment of incomplete abortion [J].
Blanchard, K ;
Taneepanichskul, S ;
Kiriwat, O ;
Sirimai, K ;
Svirirojana, N ;
Mavimbela, N ;
Winikoff, B .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (05) :860-865
[2]   Misoprostol used alone for the termination of early pregnancy - A review of the evidence [J].
Blanchard, K ;
Winikoff, B ;
Ellertson, C .
CONTRACEPTION, 1999, 59 (04) :209-217
[3]  
BLUST D, 2002, OBSTET GYNECOL, V97, pS5
[4]   Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion [J].
Bugalho, A ;
Faundes, A ;
Jamisse, L ;
Usfa, M ;
Maria, E ;
Bique, C .
CONTRACEPTION, 1996, 53 (04) :243-246
[5]  
Carbonell J L, 1997, Eur J Contracept Reprod Health Care, V2, P181
[6]   Oral and vaginal misoprostol 800 μg every 8 h for early abortion [J].
Carbonell, JLL ;
Rodríguez, J ;
Velazco, A ;
Tanda, R ;
Sánchez, C ;
Barambio, S ;
Chami, S ;
Valero, F ;
Marí, J ;
de Vargas, F ;
Salvador, I .
CONTRACEPTION, 2003, 67 (06) :457-462
[7]   Vaginal Misoprostol 1000 μg for early abortion [J].
Carbonell, JLL ;
Rodriguez, J ;
Aragón, S ;
Velazco, A ;
Tanda, R ;
Sánchez, C ;
Barambio, S ;
Chami, S ;
Valero, F .
CONTRACEPTION, 2001, 63 (03) :131-136
[8]   Oral methotrexate and vaginal misoprostol for early abortion [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Cabezas, E ;
Fernández, C ;
Sánchez, C .
CONTRACEPTION, 1998, 57 (02) :83-88
[9]   The use of misoprostol for termination of early pregnancy [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Fernandez, C .
CONTRACEPTION, 1997, 55 (03) :165-168
[10]   Buccal versus intravaginal misoprostol administration for cervical ripening [J].
Carlan, SJ ;
Blust, D ;
O'Brien, WF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (02) :229-233